Townshend-Bulson L - Search Results

1

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.

Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, Spradling PR, Baum R, Hennessy T, McMahon BJ. Bruce MG, et al. J Infect Dis. 2016 Jul 1;214(1):16-22. doi: 10.1093/infdis/jiv748. Epub 2016 Jan 21. J Infect Dis. 2016. PMID: 26802139

2

Cascade of Care for Alaska Native People With Chronic Hepatitis C Virus Infection: Statewide Program With High Linkage to Care.

Mcmahon BJ, Townshend-Bulson L, Homan C, Gounder P, Barbour Y, Hewitt A, Bruden D, Espera H, Plotnik J, Gove J, Stevenson TJ, Luna SV, Simons BC. Mcmahon BJ, et al. Among authors: townshend bulson l. Clin Infect Dis. 2020 Apr 15;70(9):2005-2007. doi: 10.1093/cid/ciz832. Clin Infect Dis. 2020. PMID: 31504307 Free PMC article.

3

Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.

Livingston SE, Deubner H, Bruden DL, McMahon BJ, Homan CE, Townshend-Bulson LJ, Bruce MG, Hennessy TW, Williams JL, Gretch DR. Livingston SE, et al. Can J Gastroenterol. 2010 Jul;24(7):445-51. doi: 10.1155/2010/692036. Can J Gastroenterol. 2010. PMID: 20652161 Free PMC article.

4

Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection.

Livingston SE, Townshend-Bulson LJ, Bruden DL, McMahon BJ, Homan CE, Gove JE, Deubner H, Bruce MG, Robinson RF, Gretch DR. Livingston SE, et al. Int J Circumpolar Health. 2012 Apr 24;71:1-7. doi: 10.3402/ijch.v71i0.18445. Int J Circumpolar Health. 2012. PMID: 22564468 Free PMC article.

5

Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C.

Livingston SE, Townshend-Bulson LJ, Bruden DJ, Homan CE, Gove JE, Plotnik JN, Simons BC, Spradling PR, McMahon BJ. Livingston SE, et al. Among authors: townshend bulson lj. Int J Circumpolar Health. 2016 Mar 29;75:30696. doi: 10.3402/ijch.v75.30696. eCollection 2016. Int J Circumpolar Health. 2016. PMID: 27029671 Free PMC article.

6

Prevalence and correlates of hepatitis C virus-associated inflammatory arthritis in a population-based cohort.

Ferucci ED, Choromanski TL, Varney DT, Ryan HS, Townshend-Bulson LJ, McMahon BJ, Wener MH. Ferucci ED, et al. Among authors: townshend bulson lj. Semin Arthritis Rheum. 2017 Dec;47(3):445-450. doi: 10.1016/j.semarthrit.2017.04.004. Epub 2017 Apr 24. Semin Arthritis Rheum. 2017. PMID: 28532574

7

Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.

McMahon BJ, Bruden D, Townshend-Bulson L, Simons B, Spradling P, Livingston S, Gove J, Hewitt A, Plotnik J, Homan C, Espera H, Negus S, Snowball M, Barbour Y, Bruce M, Gounder P. McMahon BJ, et al. Among authors: townshend bulson l. Clin Gastroenterol Hepatol. 2017 Mar;15(3):431-437.e2. doi: 10.1016/j.cgh.2016.10.012. Epub 2016 Oct 17. Clin Gastroenterol Hepatol. 2017. PMID: 27765729 Free PMC article.

8

Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?

Gounder PP, Haering C, Bruden DJT, Townshend-Bulson L, Simons BC, Spradling PR, McMahon BJ. Gounder PP, et al. Among authors: townshend bulson l. J Clin Gastroenterol. 2018 Jan;52(1):60-66. doi: 10.1097/MCG.0000000000000753. J Clin Gastroenterol. 2018. PMID: 27875352

9

Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.

Bruden DJT, McMahon BJ, Townshend-Bulson L, Gounder P, Gove J, Plotnik J, Homan C, Hewitt A, Barbour Y, Spradling PR, Simons BC, McArdle S, Bruce M. Bruden DJT, et al. Among authors: townshend bulson l. Hepatology. 2017 Jul;66(1):37-45. doi: 10.1002/hep.29115. Epub 2017 May 22. Hepatology. 2017. PMID: 28195349 Free PMC article.

10

Observed Changes in Natural Killer and T cell Phenotypes with Evaluation of Immune Outcome in a Longitudinal Cohort Following Sofosbuvir-Based Therapy for Chronic Hepatitis C Infection.

Stevenson TJ, Barbour Y, McMahon BJ, Townshend-Bulson L, Hewitt AM, Espera HGF, Homan C, Holck P, Luna SV, Knall C, Simons BC. Stevenson TJ, et al. Among authors: townshend bulson l. Open Forum Infect Dis. 2019 May 17;6(6):ofz223. doi: 10.1093/ofid/ofz223. eCollection 2019 Jun. Open Forum Infect Dis. 2019. PMID: 31249845 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page